Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Phase II
Biotech
Windtree's shock med raises blood pressure in latest phase 2 win
While Windtree has struggled to grow the financial roots to thrive, a win for its lead asset should give the company encouragement to persevere.
James Waldron
Sep 25, 2024 9:59am
Roivant's inflammatory med is back on track with ph. 2 NIU data
Apr 2, 2024 10:37am
ZyVersa taps George Clinical to run kidney disease trial
Dec 20, 2023 4:51pm
Psychiatry biotech hopes to Transcend PTSD rivals with new data
Dec 5, 2023 5:45pm
Agios' next-up PK med quelled transfusion need in some patients
Nov 20, 2023 11:24am
Amgen's tarlatamab BiTEs at SCLC in brief readout
Aug 3, 2023 4:01pm